Elwood D. Howse, Director at Capstone Therapeutics Corp. (CAPS), bought 50,000 shares at $0.49 ($25K) on 2010-12-22, disclosed to the SEC on 2010-12-23.
Open-market purchase of $24k CAPS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| OLGC | BUY | 2008-09-11 | $25K | — | Filing → |